Biomune Names Joseph Charles & Associates Investment Banker.SALT LAKE CITY--(BUSINESS WIRE)--Aug. 5, 1998--Biomune Systems, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :BIME) today announced that the company has retained Joseph Charles & Associates, Inc. as its investment banker Investment Banker A person representing a financial institution that is in the business of raising capital for corporations and municipalities. Notes: An investment banker may not accept deposits or make commercial loans. and financial advisor. Joseph Charles will advise Biomune on strategic planning Strategic planning is an organization's process of defining its strategy, or direction, and making decisions on allocating its resources to pursue this strategy, including its capital and people. , execution of acquisitions and overall business development. Joseph Charles & Associates is a full service investment firm offering investment banking services and institutional research through its Capital Markets Group. The firm's headquarters are in Boca Raton Boca Raton (bō`kə rətōn`), city (1990 pop. 61,492), Palm Beach co., SE Fla., on the Atlantic; inc. 1925. Boca Raton is a popular resort and retirement community that experienced significant industrial development in the 1970s and 80s. , Fla., with eight offices located throughout the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. . Biomune Systems, Inc. is a biopharmaceutical research and development company that began researching the various applications of its patented whey protein whey protein, n soluble protein found in milk whey that has been clotted by rennin, examples of which include alpha-lactalbumin, lactoglobulin, and lactoferrin. (Biomune Whey Protein Technology) in immune-compromised individuals and cancer research. Biomune Systems, Inc.'s wholly-owned subsidiary, Optim Nutrition, Inc. is engaged in manufacturing, new product development and marketing of nutraceutical, functional foods and dietary supplements Noun 1. dietary supplement - something added to complete a diet or to make up for a dietary deficiency diet - a prescribed selection of foods vitamin pill - a pill containing one or more vitamins; taken as a dietary supplement . Biomune's 52 percent owned subsidiary, Rockwood Companies, is a leading provider of quality health, beauty and cosmetic aids, creating and producing superior products and marketing them through distribution in chain stores and mass merchandisers utilizing celebrity spokespersons in their lines of products. In addition, the company manufactures a number of private label products for major chains in the United States. This press release may contain forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. about the company's goals and anticipated future performance. The industry in which the company proposes to operate is dynamic and intensely competitive and there are many factors that could cause the forward-looking statements contained herein not to occur or the timing of their occurrence to be delayed. With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing studies and trials, economic conditions, product and technology development, production efficiencies, product demand, competitive products and the competitive environment, availability of raw materials and critical manufacturing equipment and facilities, and other risks identified in filings made with the Securities and Exchange Commission.
CONTACT: Martin E. Janis & Co., Inc.
Bev Jedynak, 312/943-1100
|
|
||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion